How Long Do Allergy Shots Stay in Your System? Extract vs. Immune Memory

Because allergen extract clears from tissue within 2-6 hours and does not maintain a blood drug level, allergy shots have no meaningful drug interactions through standard metabolic pathways. The primary drug concern in SCIT is not the allergen extract itself but the rescue medication — specifically, beta-blockers impair the response to epinephrine used to treat anaphylaxis, which is why beta-blockers are a relative contraindication for SCIT. ACE inhibitors have historically been listed as a relative contraindication for venom immunotherapy, though contemporary prospective data (Sturm et al., Allergy 2021, n=1,425) found beta-blockers and ACE inhibitors did not increase adverse event rates during VIT. The concern is about epinephrine rescue effectiveness if a reaction occurs, not about pharmacokinetic interaction with the allergen extract itself.

Allergy shots can be safely continued during pregnancy at the current maintenance dose — there is no 'clearance period' required before conception, and no need to stop allergy shots when pregnancy is confirmed if you are already at maintenance. The AAAAI/ACAAI Practice Parameter notes that SCIT can be maintained during pregnancy at the existing dose (Metzger et al., JACI 1978). However, the recommendation is to NOT increase the dose during pregnancy — dose escalation carries higher systemic reaction risk, and epinephrine used to treat anaphylaxis carries risks in pregnancy. New SCIT courses are not typically initiated during pregnancy. The extract clears from tissue within hours of each injection, so there is no accumulation or 'washout period' consideration for pregnancy planning.

There is no need to stop or 'clear' allergy shots before elective surgery. The allergen extract clears from tissue within hours of each injection, so there is no meaningful allergen load remaining by the time most surgical procedures are scheduled. The standard practice recommendation is simply to maintain the normal injection interval — a gap of more than 24 hours between the last shot and surgery is standard and sufficient. Most allergists recommend scheduling the last pre-surgery injection at the normal interval and resuming the normal schedule post-operatively without dose reduction unless a significant gap has accumulated. The immunological changes from allergy shots do not interfere with anesthesia, wound healing, or postoperative immune function.

Regular injections during the build-up and maintenance phases are needed not to maintain a drug level but to keep training and reinforcing the immune system's tolerance response. During build-up, each injection delivers a higher allergen dose that progressively escalates immune training signals. During maintenance, monthly injections sustain the IgG4 blocking antibody pool and continue stimulating regulatory T-cell populations — without ongoing allergen exposure, IgG4 levels would gradually decline (half-life approximately 21 days) and the tolerogenic immune environment would slowly attenuate. The analogy is to regular physical exercise: you don't stop after reaching peak fitness, because fitness is maintained by ongoing training, not by a drug level. After completing the full 3-5 year course, the immune education becomes self-sustaining enough to persist without further injections for years.

Aluminum hydroxide adjuvant used in some allergy shot formulations creates a subcutaneous depot at the injection site that may persist locally for weeks to months, releasing allergen slowly to prolong immune stimulation. Systemic aluminum is cleared renally within days (Keith et al., Allergy Asthma Clin Immunol 2012). The total aluminum load from allergy shots over a full course is small relative to dietary aluminum intake and far below levels associated with any documented health risk. The FDA and AAAAI have not identified aluminum-containing allergy shot adjuvants as posing a health concern at standard therapeutic doses. Some formulations (aqueous extracts) contain no aluminum adjuvant at all. Local reactions at the injection site may partially reflect the adjuvant depot, but these are self-limited.

Immune memory from allergy shots — specifically the regulatory T-cell populations and IgG4-producing B-cell memory established during treatment — persists beyond measurable antibody levels and underlies the documented post-treatment benefit of 3-12 years. IgG4 blocking antibodies decline with a 21-day half-life after stopping treatment but remain above pre-treatment baseline for approximately 2-3 years (Shamji and Durham, JACI 2017). Regulatory T-cell populations in tissue persist even longer than the antibody response. Durham et al. (NEJM 1999, JACI 2012) documented sustained grass pollen benefit at 3-7 years post-treatment; Eng et al. (Allergy 2006) documented sustained benefit at 12 years in a small but intensively followed cohort. The depth of immune memory appears related to treatment duration — patients completing 5 years retain it longer than those stopping at 3 years.